George Mashour, M.D., Ph.D. appointed senior associate dean for faculty and faculty development

George Mashour, M.D., Ph.D. standing in front of a bookcase, smiling. He is wearing a dark suit, white shirt, dark striped tie and dark framed glasses.

George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024. 

Mashour served as chair of the U-M Medical School Department of Anesthesiology and the Robert B. Sweet Professor of Anesthesiology since December 2019. Prior to his chair appointment, he served as associate dean for clinical and translational research and director of the Michigan Institute for Clinical and Health Research (MICHR). In 2022, he founded the Michigan Psychedelic Center, which he directs. He also founded the U-M Center for Consciousness Science in 2014. 

“The expertise, energy, and dedication of our incredible faculty members play a central role in actualizing our tripartite mission of clinical care, education, and research. I feel privileged and grateful to be able to serve them as senior associate dean for faculty and faculty development,” said Mashour.

Mashour received his medical degree and doctorate in neuroscience from Georgetown University and studied neuroscience as a Fulbright Scholar in Berlin and Bonn. After completing residency and chief residency at Harvard Medical School and Massachusetts General Hospital, he pursued a neurosurgical anesthesiology fellowship at Michigan Medicine.

In 2007, Mashour was appointed assistant professor in the departments of anesthesiology and neurosurgery, with an additional faculty appointment in the Neuroscience Graduate Program. He was promoted to professor in 2017 and appointed professor of pharmacology in 2021.

Mashour is an internationally recognized expert on the neurobiology of consciousness and unconsciousness. He conducts NIH-funded neuroscience research across the translational spectrum, from computational models to laboratory science to clinical trials.

He recently served as president of the Association of University Anesthesiologists and as a trustee of the International Anesthesia Research Society. His many awards and honors include the Excellence in Research Award from the American Society of Anesthesiologists, election as a Fellow of the American Association for the Advancement of Science, and election to the National Academy of Medicine.

Mashour succeeds Brian Zink, M.D., professor of emergency medicine, who served in the position from September 2019 to December 2023 and Laurel Moore, M.D., clinical professor of anesthesiology and neurosurgery, who served in an interim role since January 2024.

Featured News & Stories

liver with yellow circles over it
Health Lab

Evolving causes, diagnosis of drug-induced liver injury

The causes of drug-induced liver injury have evolved over the last 20 years, according to a review in Hepatology Communications.
Teen girl sitting on floor next to her bed looking at a smartphone, with icons from social media apps layered over her as she frowns
Health Lab

How to improve mental health safety on social media – not just for young people

With social media companies losing or settling court cases about their products' impact on young peoples' mental health, experts offer tips for reducing impacts for those who use the platforms.
lab tests purple tops
Health Lab

Blood-based multi-cancer screening tests: Ready for primetime?

Blood-based multi-cancer screening tests may hold promise, but U-M experts recommend proven cancer screening methods and genetic risk assessment first.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has extended public comment on proposed temporary rescheduling of 7-OH and has rescheduled three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
microbes inside gut yellow
Health Lab

New oral nanomedicine boosts effectiveness of cancer immunotherapies

University of Michigan researchers developed an oral drug that can increase the ability of T cells to attack tumors. The drug uses the microbial metabolite 3,4-dihydroxybenzoic acid, which is derived from dietary fiber.
blue background bucket poured on helment
Health Lab

5 things to know about ALS

A Michigan Medicine expert answers questions about this degenerative neurological disease and the work in process to defeat it.